Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Opaleye Management Inc.


  • Large Shareholder at Tracon Pharmaceuticals Inc. (TCON), 2020-10-24
  • Large Shareholder at Eton Pharmaceuticals Inc. (ETON), 2020-10-17
  • Large Shareholder at Protara Therapeutics Inc. (TARA), 2020-10-02
  • Large Shareholder at Harrow Health Inc. (HROW), 2020-07-15
  • Other at Ocular Therapeutix Inc (OCUL), 2020-04-03
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TCON $4.40 5,656 Large Shareholder 1,797,094 2020-10-21 Filing
TCON $4.40 3,000 Large Shareholder 225,000 2020-10-21 Filing
ETON $7.00 15,000 Large Shareholder 155,000 2020-10-16 Filing
ETON $7.00 385,000 Large Shareholder 3,885,000 2020-10-16 Filing
TARA $16.00 50,000 Large Shareholder 2,458,472 2020-09-30 Filing